Roche raises bid for Genentech to $93 a share

Swiss conglomerate Roche says that it has raised its offer to acquire the shares of Genentech Inc. that it does not already own to $93 a share from $86.50 a share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.